CN107523552B - 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 - Google Patents
分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 Download PDFInfo
- Publication number
- CN107523552B CN107523552B CN201710585822.4A CN201710585822A CN107523552B CN 107523552 B CN107523552 B CN 107523552B CN 201710585822 A CN201710585822 A CN 201710585822A CN 107523552 B CN107523552 B CN 107523552B
- Authority
- CN
- China
- Prior art keywords
- amh
- monoclonal antibody
- hybridoma cell
- immunoassay kit
- cgmcc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 21
- 230000003248 secreting effect Effects 0.000 title claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims abstract description 21
- 238000002965 ELISA Methods 0.000 claims abstract description 10
- 238000000338 in vitro Methods 0.000 claims abstract description 6
- 238000004321 preservation Methods 0.000 claims abstract description 6
- 238000009629 microbiological culture Methods 0.000 claims abstract description 4
- 238000003018 immunoassay Methods 0.000 claims description 9
- 230000007910 cell fusion Effects 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
- 210000004989 spleen cell Anatomy 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 14
- 210000002966 serum Anatomy 0.000 abstract description 12
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 24
- 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 24
- 239000000868 anti-mullerian hormone Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 206010003445 Ascites Diseases 0.000 description 8
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- 210000000683 abdominal cavity Anatomy 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000002710 gonadal effect Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003118 sandwich ELISA Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 101001011645 Homo sapiens Muellerian-inhibiting factor Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000002332 leydig cell Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000005001 male reproductive tract Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
浓度(ng/ml) | 复孔1 | 复孔1 | 均值 |
27.00 | 3.173 | 3.146 | 3.1595 |
9.00 | 2.457 | 2.316 | 2.3865 |
3.00 | 1.202 | 1.107 | 1.1545 |
1.00 | 0.463 | 0.444 | 0.4535 |
0.33 | 0.208 | 0.209 | 0.2085 |
0.11 | 0.143 | 0.151 | 0.147 |
0.04 | 0.087 | 0.086 | 0.0865 |
胎牛血清 | 0.067 | 0.062 | 0.0645 |
AMH-1 | AMH-2 | |
IgA | 0.116 | 0.167 |
IgM | 0.101 | 0.18 |
IgG1 | 0.146 | 0.199 |
IgG2a | 1.14 | 0.101 |
IgG2b | 0.185 | 2.696 |
IgG3 | 0.118 | 0.184 |
Ig-λ | 0.15 | 0.185 |
Ig-κ | 0.964 | 1.679 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710585822.4A CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710585822.4A CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107523552A CN107523552A (zh) | 2017-12-29 |
CN107523552B true CN107523552B (zh) | 2020-11-10 |
Family
ID=60749052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710585822.4A Active CN107523552B (zh) | 2017-07-18 | 2017-07-18 | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107523552B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109180814A (zh) * | 2018-09-10 | 2019-01-11 | 宁波奥丞生物科技有限公司 | 一种抗缪勒氏管激素的抗体制备方法 |
CN111196851B (zh) * | 2018-11-20 | 2021-11-16 | 厦门万泰凯瑞生物技术有限公司 | 针对人抗缪勒管激素的特异性抗体及其应用 |
CN110128535A (zh) * | 2019-03-27 | 2019-08-16 | 浙江工业大学 | 一种amh单克隆抗体及其制备与应用 |
CN111004326A (zh) * | 2019-12-27 | 2020-04-14 | 苏州博方生物技术有限公司 | 一种抗amh单克隆抗体及其制备方法和应用 |
CN114478764A (zh) * | 2020-11-12 | 2022-05-13 | 东莞市朋志生物科技有限公司 | 抗amh的抗体、检测amh的试剂和试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106674348A (zh) * | 2017-01-06 | 2017-05-17 | 刘玲 | 抗苗勒管激素抗体及其制备方法 |
-
2017
- 2017-07-18 CN CN201710585822.4A patent/CN107523552B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106674348A (zh) * | 2017-01-06 | 2017-05-17 | 刘玲 | 抗苗勒管激素抗体及其制备方法 |
Non-Patent Citations (2)
Title |
---|
Assessment of the Access AMH assay as an automated,high-performance replacement for the AMH Generation II manual ELISA;Pearson K等;《Reproductive Biology & Endocrinology》;20161231;第14卷;第1-9页 * |
Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome;Mumford SL等;《J.Clin Endocrinol Metab》;20161231;第101卷;第3288-3296页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107523552A (zh) | 2017-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107523552B (zh) | 分泌抗amh单克隆抗体的杂交瘤细胞株、抗amh单克隆抗体及应用 | |
CN112079920A (zh) | 一种用于检测SARS-CoV-2病毒N蛋白的单克隆抗体及其应用 | |
CN111217907B (zh) | 抗amh单克隆抗体及其应用 | |
CN105112398A (zh) | 一种杂交瘤细胞的制备及其分泌的单抗与应用 | |
CN104357401B (zh) | 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
CN112625124A (zh) | 一种新型冠状病毒蛋白的快速免疫方法及其应用 | |
CN113049818A (zh) | 一种鉴别突变型抗原的方法及试剂 | |
WO2019000267A1 (zh) | Gm杂交瘤细胞、单克隆抗体、试剂盒及其制备方法与应用 | |
CN112457392A (zh) | 一种可溶性st2蛋白抗原决定簇多肽及其应用 | |
CN111587252B (zh) | 与牛妊娠相关糖蛋白1特异性结合的抗体及其用途 | |
CN115806611B (zh) | 抗新型冠状病毒n蛋白的抗体及其应用 | |
CN111334479A (zh) | 一株氯羟吡啶单克隆抗体杂交瘤细胞株tyl及其应用 | |
CN114276456B (zh) | 分泌鼠抗人IgG单克隆抗体的杂交瘤细胞株及其分泌的单克隆抗体和应用 | |
CN114164181B (zh) | 一种产生牛妊娠相关糖蛋白pag8单克隆抗体的杂交瘤细胞株及其应用 | |
CN109402063B (zh) | 抗猪血红蛋白杂交瘤细胞株及其单克隆抗体与应用 | |
CN115651915A (zh) | 分泌抗猫b型血型特异性单克隆抗体的杂交瘤细胞株、单克隆抗体及其应用 | |
CN113999817A (zh) | 半乳糖凝集素-3鼠杂交瘤细胞、单克隆抗体、检测试剂盒及检测方法 | |
CN111217910B (zh) | 单克隆抗体对及其在检测髓过氧化物酶蛋白中的应用 | |
CN108219002B (zh) | 一种重组的c肽免疫原及其应用 | |
JP4663831B2 (ja) | モノクローナル抗体、細胞株及びn1,n12−ジアセチルスペルミンの測定法 | |
CN112062847A (zh) | 一种inhb抗体及其应用 | |
CN114836389B (zh) | 分泌抗hcg单克隆抗体的杂交瘤细胞株、抗hcg单克隆抗体及应用 | |
CN114395533B (zh) | 分泌抗人Cys C单克隆抗体的杂交瘤细胞株及其分泌的单克隆抗体和应用 | |
WO2023245801A1 (zh) | 一种抗念珠菌甘露聚糖单克隆抗体及其应用 | |
CN110079506B (zh) | 一种人血清纤维胶凝蛋白ficolin-2的单克隆抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240604 Address after: Room 201, Building 5, No. 519 Xingguo Road, Qianjiang Economic Development Zone, Hangzhou City, Zhejiang Province, 310000 Patentee after: HANGZHOU BIOGENOME BIOTECHNOLOGY CO.,LTD. Country or region after: China Patentee after: Chongqing Boshengte Biotechnology Co.,Ltd. Address before: Room 201, Building 5, No. 519 Xingguo Road, Qianjiang Economic Development Zone, Hangzhou City, Zhejiang Province, 310000 Patentee before: HANGZHOU BIOGENOME BIOTECHNOLOGY CO.,LTD. Country or region before: China |
|
TR01 | Transfer of patent right |